PARPis As Immune Modulating Agents in Preventing Ovarian Cancer Recurrence

Authors

Melayshia McFadden, Morehouse School of MedicineFollow
Natalie Ngoi, The University of Texas MD Anderson Cancer Center
Xueqian Cheng, The University of Texas MD Anderson Cancer CenterFollow
Guang Peng, The University of Texas MD Anderson Cancer CenterFollow

Files

Keywords

ovarian cancer; parp inhibitors; BRCA; recurrence; immune response

Program Affiliation

CPRTP Summer Research Experience

Recommended Citation

McFadden, Melayshia; Ngoi, Natalie; Cheng, Xueqian; and Peng, Guang, "PARPis As Immune Modulating Agents in Preventing Ovarian Cancer Recurrence" (2022). Summer Experience 2022. 142.
https://openworks.mdanderson.org/sumexp22/142